AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,483,886 | -3.1% | 286,504 | +0.1% | 0.34% | -0.9% |
| Q2 2023 | $3,593,981 | +49.7% | 286,145 | +32.2% | 0.34% | +36.7% |
| Q1 2023 | $2,400,530 | -8.8% | 216,459 | +0.4% | 0.25% | -12.2% |
| Q4 2022 | $2,633,526 | +17.3% | 215,686 | +0.3% | 0.29% | +15.3% |
| Q3 2022 | $2,245,000 | +6.5% | 215,069 | +9.6% | 0.25% | +13.2% |
| Q2 2022 | $2,107,000 | +55.4% | 196,196 | +37.0% | 0.22% | +81.0% |
| Q1 2022 | $1,356,000 | -17.4% | 143,221 | +0.8% | 0.12% | -16.6% |
| Q4 2021 | $1,641,000 | +11.0% | 142,064 | -0.6% | 0.14% | +9.0% |
| Q3 2021 | $1,479,000 | +8.8% | 142,864 | +1.3% | 0.13% | -32.1% |
| Q2 2021 | $1,360,000 | -5.2% | 141,064 | -2.8% | 0.20% | +14.0% |
| Q1 2021 | $1,434,000 | -43.5% | 145,064 | +32.1% | 0.17% | -48.3% |
| Q4 2020 | $2,537,000 | – | 109,855 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Morgenthaler Management Partners IX, LLC | 1,783,948 | $17,304,000 | 18.83% |
| FRAZIER MANAGEMENT LLC | 2,918,291 | $28,307,000 | 11.84% |
| Avoro Capital Advisors LLC | 3,515,611 | $34,101,000 | 11.75% |
| Perceptive Advisors | 15,239,444 | $147,823,000 | 10.94% |
| Redmile Group, LLC | 10,280,620 | $99,722,000 | 7.46% |
| ACUTA CAPITAL PARTNERS, LLC | 1,502,661 | $14,576,000 | 6.97% |
| SECTORAL ASSET MANAGEMENT INC | 7,973,436 | $77,342,000 | 3.30% |
| Asymmetry Capital Management, L.P. | 195,206 | $1,893,000 | 2.86% |
| Convector Capital Management, LP | 210,500 | $2,042,000 | 1.92% |
| Palo Alto Investors LP | 3,551,173 | $34,446,000 | 1.92% |